STF Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $572K | Buy |
1,089
+42
| +4% | +$22.1K | 0.23% | 85 |
|
|
2025
Q1 | $664K | Buy |
1,047
+79
| +8% | +$50.1K | 0.32% | 71 |
|
|
2024
Q4 | $690K | Sell |
968
-589
| -38% | -$420K | 0.31% | 70 |
|
|
2024
Q3 | $1.64M | Sell |
1,557
-157
| -9% | -$165K | 0.74% | 32 |
|
|
2024
Q2 | $1.8M | Sell |
1,714
-75
| -4% | -$78.8K | 0.76% | 31 |
|
|
2024
Q1 | $1.72M | Sell |
1,789
-37
| -2% | -$35.6K | 0.75% | 32 |
|
|
2023
Q4 | $1.6M | Buy |
1,826
+72
| +4% | +$63.2K | 0.75% | 36 |
|
|
2023
Q3 | $1.44M | Buy |
1,754
+1,077
| +159% | +$886K | 0.77% | 32 |
|
|
2023
Q2 | $486K | Sell |
677
-544
| -45% | -$391K | 0.52% | 34 |
|
|
2023
Q1 | $1M | Buy |
1,221
+506
| +71% | +$416K | 0.68% | 31 |
|
|
2022
Q4 | $516K | Buy |
+715
| New | +$516K | 0.74% | 33 |
|